ALB and glioma: Two glioma cell lines are investigated here, for the first time, in the context of albumin conjugates to align with other research in our lab, in which new compounds and methods that enable blood–brain barrier (BBB) opening, and thus, the entrance of large therapeutic molecules such as albumin are being developed [14,15,16,17,18].